Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gisselbrecht

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
Bone Marrow Transplantation|September 1, 2000
Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignanciesS Park, P Brice, M E Noguerra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
MHC related genetic susceptibility to Hodgkin's diseaseI Kalidi, M Masset, J Gony, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimenA Bosly, B Coiffier, C Gisselbrecht, et al.
Leukemia & Lymphoma|August 1, 1996
Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cellsP Brice, J P Marolleau, P Pautier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2008
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapyI Biasoli, P Franchi-Rezgui, D Sibon, et al.
Nouvelle Revue Francaise D'Hematologie|August 1, 1993
Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scanP Brice, J D Rain, J Frija, et al.
Bone Marrow Transplantation|May 1, 1992
Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomasP Brice, J P Marolleau, H Dombret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's diseaseP Brice, J Tredaniel, J J Monsuez, et al.
Pathologie-Biologie|February 1, 1987
[The role of zorubicine in the treatment of acute myeloid leukemia. Evaluation of 15 years' use]M Marty, C Gisselbrecht, G Schaison, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|September 1, 2000
Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignanciesS Park, P Brice, M E Noguerra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
MHC related genetic susceptibility to Hodgkin's diseaseI Kalidi, M Masset, J Gony, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimenA Bosly, B Coiffier, C Gisselbrecht, et al.
Leukemia & Lymphoma|August 1, 1996
Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cellsP Brice, J P Marolleau, P Pautier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2008
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapyI Biasoli, P Franchi-Rezgui, D Sibon, et al.
Nouvelle Revue Francaise D'Hematologie|August 1, 1993
Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scanP Brice, J D Rain, J Frija, et al.
Bone Marrow Transplantation|May 1, 1992
Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomasP Brice, J P Marolleau, H Dombret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's diseaseP Brice, J Tredaniel, J J Monsuez, et al.
Pathologie-Biologie|February 1, 1987
[The role of zorubicine in the treatment of acute myeloid leukemia. Evaluation of 15 years' use]M Marty, C Gisselbrecht, G Schaison, et al.
Pageof 22